Journals / Turkish Journal of Biology / 2009 / Cilt: 33 - Sayı: 2

Comparison of GST Isoenzyme Expression in Normal and Neoplastic Breast Tissue: Correlation with Clinical and Prognostic Factors

Pages
89–100
Publication Date
2009-02-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The relationships between GST isoenzyme expression, and estrogen receptor status, tumor grade, smoking status, chemotherapy status, parity, patient´s age, and hormone therapy status were not statistically significant (P > 0.05).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Glutathione S-transferases in breast tissue play an important role in the susceptibility to the mutagenic effects of chemical carcinogens and in the response of breast tumors to chemotherapy.
📊
Key Findings & Data:In this study the immunohistochemical staining characteristics of glutathione S-transferase isoenzymes (alpha, mu, pi, and theta) were investigated in invasive duct carcinomas and in normal breast tissue of 43 patients.
💡
Conclusion & Impact:The relationships between GST isoenzyme expression, and estrogen receptor status, tumor grade, smoking status, chemotherapy status, parity, patient´s age, and hormone therapy status were not statistically significant (P > 0.05).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Glutathione-S-transferase · breast cancer · immunohistochemistry

Abstract

Glutathione S-transferases in breast tissue play an important role in the susceptibility to the mutagenic effects of chemical carcinogens and in the response of breast tumors to chemotherapy. In this study the immunohistochemical staining characteristics of glutathione S-transferase isoenzymes (alpha, mu, pi, and theta) were investigated in invasive duct carcinomas and in normal breast tissue of 43 patients. The relationships between the expression of the GST isoenzymes and some clinicopathological features were also examined. Diffuse cytoplasmic staining of varying intensity was observed for GST alpha, theta, and pi in normal and tumorous breast tissue in 100% of the samples. In normal epithelium there was a stronger intensity of staining for GST alpha, mu, and pi expression than in invasive tumor tissues (P < 0.05); however, it was statistically proven that in normal and tumor epithelial cells there was no significant difference in the GST theta isoenzyme staining scores (P > 0.05). In this study significant relationships were observed between microcalcification status and GST mu, between menopause status and GST alpha, and between tumor grade and GST mu expression (P < 0.05). The relationships between GST isoenzyme expression, and estrogen receptor status, tumor grade, smoking status, chemotherapy status, parity, patient´s age, and hormone therapy status were not statistically significant (P > 0.05).

Özet

Glutathione S-transferases in breast tissue play an important role in the susceptibility to the mutagenic effects of chemical carcinogens and in the response of breast tumors to chemotherapy. In this study the immunohistochemical staining characteristics of glutathione S-transferase isoenzymes (alpha, mu, pi, and theta) were investigated in invasive duct carcinomas and in normal breast tissue of 43 patients. The relationships between the expression of the GST isoenzymes and some clinicopathological features were also examined. Diffuse cytoplasmic staining of varying intensity was observed for GST alpha, theta, and pi in normal and tumorous breast tissue in 100% of the samples. In normal epithelium there was a stronger intensity of staining for GST alpha, mu, and pi expression than in invasive tumor tissues (P < 0.05); however, it was statistically proven that in normal and tumor epithelial cells there was no significant difference in the GST theta isoenzyme staining scores (P > 0.05). In this study significant relationships were observed between microcalcification status and GST mu, between menopause status and GST alpha, and between tumor grade and GST mu expression (P < 0.05). The relationships between GST isoenzyme expression, and estrogen receptor status, tumor grade, smoking status, chemotherapy status, parity, patient´s age, and hormone therapy status were not statistically significant (P > 0.05).

🔖

Cite This Article

OĞUZTÜZÜN, S., İŞCAN, M., ÖZHAVZALI, M., SAK, S. D. (2009). Comparison of GST Isoenzyme Expression in Normal and Neoplastic Breast Tissue: Correlation with Clinical and Prognostic Factors. Turkish Journal of Biology, Cilt: 33 - Sayı: 2, 89–100. https://ajindex.com/articles/182267

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Harris JR, Lippman ME, Veronesi U et al. Breast Cancer. N Engl J Med 327: 319-328, 1992
  2. Kelsey JL, Berkowitz GS. Breast Cancer Epidemiology. Cancer Res. 48: 5615-5623, 1988
  3. Henderson IC. Risk factors for breast cancer development. Cancer (suppl.) 71: 2127-2140, 1993
  4. Li D, Wang M, Dhingra K et al. Aromatic DNA adducts in adjacent tissues of breast cancer patients: Clues to breast cancer etiology. Cancer Res. 56:287-293, 1996
  5. Hayes JD, Flaagan JU, Jowsey IR. Glutathione-S-Transferases. Annu Rev Pharmacol Toxicol 45: 51-88, 2005
  6. Coles BF, Kadlubar FF. Detoxification of electrophilic compounds by glutathione S-transferase catalysis: determinants of individual response to chemical carcinogens and chemotherapeutic drugs? Biofactors 17: 115-130, 2003
  7. Perquin M, Oster T, Maul A et al. The glutathione-related detoxification system is increased in human breast cancer in correlation with clinical and histopathological features. J Cancer Res Clin Oncol 127: 368-374, 2001
  8. Rajneesh CP, Manimaran A, Sasikala KR et al. Lipid peroxidation and antioxidant status in patients with breast cancer. Singapore Med J 49: 640-3, 2008
  9. Cairns J, Wright C, Cattan AR et al. Immunohistochemical demonstration of glutathione S-transferases in primary human breast carcinomas. J Pathol 166: 19-25, 1992
  10. Gilbert L, Elwood LJ, Merino M et al. A pilot study of pi-class glutathione S-transferase expression in breast cancer-correlation with estrogen receptor expression and prognosis in node-negative breast cancer. J Clin Oncol 11: 49-58, 1993
  11. Wright C, Cairns J, Cantwell BJ et al. Response to mitoxantrone in advanced breast cancer: correlation with expression of c-erbB- 2 protein and glutathione S-transferases. Br J Cancer 65:271-74, 1992
  12. Sherman M, Titmuss S, Kirsch RE. Glutathione S-transferase in human organs. Biochem Int 6: 109-118, 1983
  13. Corrigall AV, Kirsch RE. Glutathione S-transferase distribution and concentration in human organs. Biochem Inter 16: 3: 443- 448, 1988
  14. Forrester LM, Hayes JD, Millis R et al. Expression of glutathione S-transferases and cytochrome P450 in normal and tumor breast tissue. Carcinogenesis 11-12: 2163-2170, 1990
  15. Shea TC, Kelley SI, Henner WD. Identification of an anionic form of GST present in many human tumors and tumor cell lines. Cancer Res. 48: 527-533, 1988
  16. Lewis AD, Forrester LM, Hayes JD et al. Glutathione enzymes in human tissues and tumor derived cell lines. Br J Cancer 60: 327- 331, 198